Global 3D Bioprinting Market 2017-2021

  • ID: 4231732
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • 3D Bioprinting Solutions
  • 3D Biotek
  • Advanced BioMatrix
  • BioBots
  • CELLINK
  • Cyfuse Biomedical K.K.
  • MORE
A 3D bioprinter is a mechanical device that can print three-dimensional biological structures such as tissue or organs. The materials used in the bioprinting process are specifically engineered and infused with living cells (except for metals and ceramics). The ancillary equipment comprises primarily of tools and devices used to cultivate the bioprinted structure.

The analysts forecast the global 3D bioprinting market to grow at a CAGR of 25.06% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global 3D bioprinting market for 2017-2021. To calculate the market size, the report considers the revenue generated by the vendors by sales of 3D bioprinters, materials used in the bioprinting process, as well as the services and ancillary equipment that are used post the bioprinting process.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global 3D Bioprinting Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- 3D Bioprinting Solutions
- 3D Biotek
- Advanced BioMatrix
- BioBots
- CELLINK
- Cyfuse Biomedical K.K.
- Digilab
- EnvisionTEC
- InSphero
- Organovo
- SHINING 3D TECH

Market drivers
- Companies providing low-cost 3D bioprinters penetrating the market
- For a full, detailed list, view the full report

Market challenges
- Inability of researchers to combine vascular supply in printed tissues and organs
- For a full, detailed list, view the full report

Market trends
- Collaboration among the end-users for knowledge sharing purposes
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3D Bioprinting Solutions
  • 3D Biotek
  • Advanced BioMatrix
  • BioBots
  • CELLINK
  • Cyfuse Biomedical K.K.
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
PART 06: Five forces analysis
  • Five forces analysis
PART 07: Market segmentation by source of revenue
  • Bioprinting materials
  • 3D Bioprinter
  • Services and ancillary equipment
PART 08: Market segmentation by application
  • Human tissue and organ generation
  • Medical testing
  • Dental
  • Prosthetics
  • Biosensors
  • Implants
  • Food and animal products
  • Cosmetics
PART 09: Geographical segmentation
  • Americas
  • EMEA
  • APAC
PART 10: Key leading countries
  • US
  • Germany
  • Japan
PART 11: Decision framework

PART 12: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 13: Market trends
  • Developments in scaffold-free bioprinting
  • Collaboration among the end-users for knowledge sharing purposes
  • Market witnessing a bullish investment pattern due to overvaluation of existing vendors
PART 14: Vendor landscape
  • Competitive scenario
PART 15: Key vendors profiles

PART 16: Appendix
  • List of abbreviations
List of Exhibits

Exhibit 01: Global 3D bioprinting market overview
Exhibit 02: Global 3D bioprinting market 2016-2021 ($ millions)
Exhibit 03: Organ transplant statistics in US 2010-2016 (thousand units)
Exhibit 04: Global optimistic scenario for 3D bioprinting market 2016-2021 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: 3D bioprinting market by sources of revenue 2016-2021 (% share)
Exhibit 07: 3D bioprinting market by sources of revenue 2016-2021 ($ millions)
Exhibit 08: Global 3D bioprinting market by bioprinting materials 2016-2021 ($ millions)
Exhibit 09: Segmentation of materials used for bioprinting
Exhibit 10: Segmentation of materials used in bioprinting 2016-2021 ($ millions)
Exhibit 11: Segmentation of materials used in bioprinting 2016-2021 (% share)
Exhibit 12: Bioprinting materials market by polymer segment 2016-2021 ($ millions)
Exhibit 13: Bioprinting materials market by metals segment 2016-2021 ($ millions)
Exhibit 14: Bioprinting materials market by bio-ink segment 2016-2021 ($ millions)
Exhibit 15: Bioprinting materials market by ceramic segment 2016-2021 ($ millions)
Exhibit 16: Global 3D bioprinting market by 3D bioprinter segment 2016-2021 ($ millions)
Exhibit 17: 3D bioprinters: Segmentation based on technology
Exhibit 18: 3D bioprinters: Segmentation based on technology 2016-2021 ($ millions)
Exhibit 19: 3D bioprinters: Segmentation based on technology 2016-2021 (% share)
Exhibit 20: 3D bioprinter market by droplet deposition 2016-2021 ($ millions)
Exhibit 21: Sub-segmentation of droplet deposition technology segment 2016-2021 ($ millions)
Exhibit 22: Sub-segmentation of droplet deposition technology segment, 2016-2021 (% share)
Exhibit 23: 3D bioprinters market by inkjet printing technology 2016-2021 ($ millions)
Exhibit 24: 3D bioprinters market by valve-based printing technology 2016-2021 ($ millions)
Exhibit 25: 3D bioprinters market by multi-phase jet solidification technology 2016-2021 ($ millions)
Exhibit 26: 3D bioprinters market by fused deposition modeling technology 2016-2021 ($ millions)
Exhibit 27: 3D bioprinter market by laser beam melting technology 2016 2021 ($ millions)
Exhibit 28: 3D bioprinters market by photo-polymerization technology 2016-2021 ($ millions)
Exhibit 29: 3D bioprinters market by stereo-lithography technology 2016-2021 ($ millions)
Exhibit 30: 3D bioprinters market by digital light processing 2016-2021 ($ millions)
Exhibit 31: 3D bioprinters market by two-photon polymerization technology 2016-2021 ($ millions)
Exhibit 32: 3D bioprinters market by magnetic levitation technology 2016-2021 ($ millions)
Exhibit 33: 3D bioprinters market by electron beam melting technology 2016-2021 ($ millions)
Exhibit 34: 3D bioprinters market by other technologies segment 2016-2021 ($ millions)
Exhibit 35: Global 3D bioprinting market by services and ancillary equipment segment 2016-2021 ($ millions)
Exhibit 36: Global 3D bioprinting market: Segmentation by application
Exhibit 37: Global 3D bioprinting market by application 2016-2021 (% share)
Exhibit 38: Global 3D bioprinting market by application 2016-2021 ($ millions)
Exhibit 39: Global 3D bioprinting market by human tissue and organ generation segment 2016-2021 ($ millions)
Exhibit 40: Global 3D bioprinting market by medical testing segment 2016-2021 ($ millions)
Exhibit 41: Global 3D bioprinting market by dental segment 2016-2021 ($ millions)
Exhibit 42: Global 3D bioprinting market by prosthetics segment 2016-2021 ($ millions)
Exhibit 43: Global 3D bioprinting market by biosensors segment 2016-2021 ($ millions)
Exhibit 44: Global 3D bioprinting market by implant segment 2016-2021 ($ millions)
Exhibit 45: Global 3D bioprinting market by food and animal products segment 2016-2021 ($ millions)
Exhibit 46: Global 3D bioprinting market by cosmetics segment 2016-2021 ($ millions)
Exhibit 47: Global 3D bioprinting market: Segmentation by geography 2016-2021 ($ millions)
Exhibit 48: Global 3D bioprinting market by geography 2016-2021 (% share)
Exhibit 49: 3D bioprinting market in Americas 2016-2021 ($ millions)
Exhibit 50: 3D bioprinting market in EMEA 2016-2021 ($ millions)
Exhibit 51: 3D bioprinting market in APAC, 2016-2021 ($ millions)
Exhibit 52: Key leading countries
Exhibit 53: Impact of drivers
Exhibit 54: Average selling price range of bio-ink in 2016 ($)
Exhibit 55: Impact of challenges
Exhibit 56: Key vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 3D Bioprinting Solutions
  • 3D Biotek
  • Advanced BioMatrix
  • BioBots
  • CELLINK
  • Cyfuse Biomedical K.K.
  • MORE
New Report Released: - Global 3D Bioprinting Market 2017-2021.

The author of the report recognizes the following companies as the key players in the global 3D bioprinting market: 3D Bioprinting Solutions, 3D Biotek, Advanced BioMatrix, BioBots, CELLINK, Cyfuse Biomedical K.K., Digilab, EnvisionTEC, InSphero, Organovo, and SHINING 3D TECH.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is collaboration among the end-users for knowledge sharing purposes. The current end-users of 3D bioprinters are mostly limited to research organizations, bioengineering laboratories, and universities. In April 2016, the Italian Regenerative Medicine Infrastructure (IRMI) has initiated the setting up of advanced infrastructure in the European region to ensure sharing of knowledge and 3D bioprinting technologies among different disciplines in the genre of regenerative medicine. The IRMI is organized and facilitated by nine Italian universities, five research organizations, and seven private societies.”

According to the report, one of the major drivers for this market is companies providing low-cost 3d bioprinters penetrating the market. 3D bioprinters are complex and much more advanced than traditional 3D printers. These complexities make the 3D bioprinter expensive to procure. However, the prices of the 3D bioprinters are witnessing a steep decline mainly due to the increasing number of new vendors entering the market. These vendors are providing low-cost 3D bioprinters to low-budget research organizations, laboratories, and universities. Ourobotics that is a startup is selling its 3D bioprinter called Revolution, which uses syringe-based extrusion technology, at the retail price of $14,000.

Further, the report states that one of the major factors hindering the growth of this market is inability of researchers to combine vascular supply in printed tissues and organs. Although the 3D bioprinting market has witnessed major breakthroughs over the years, it is far from bioprinting a fully functional organ or tissue for transplant. The researchers are successful in bioprinting parts of an organ or tissue that has cells fully capable of performing their dedicated functions. However, they haven't been able to combine vascular veins in the printed organs, though it can be printed separately.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • 3D Bioprinting Solutions
  • 3D Biotek
  • Advanced BioMatrix
  • BioBots
  • CELLINK
  • Cyfuse Biomedical K.K.
  • Digilab
  • EnvisionTEC
  • InSphero
  • Organovo
  • SHINING 3D TEC
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll